CSE:LVT - Post Discussion
Post by
waves1 on Sep 14, 2021 4:41pm
$LVT to fuel revenue growth with acquisition strategy
In a recent interview with Proactive News Room, the Head of Levitee's Mergers and Acquisitions Ken Osborne discussed their plan to fuel revenue growth with a raption national acquision strategy.
Levitee Labs ($LVT $LVT.c $LVTTF) is working towards gathering a large portfolio of cashflow assets in the health space, focused on substance abuse, addiction and mental health services.
$LVT is an all around solid company, both from a consumer and investors POV. They:
- Care about making a difference in mental health care and are working towards standardizing functional mushroom practices.
- Are positioned to become the psychedelic industry leader with significant revenue and cashflow.
You can watch the interview here:
https://ca.paidpromotionalmessages.com/companies/news/948246/levitee-labs-looking-to-be-world-s-first-listed-psychedelic-company-with-significant-revenue-and-cashflow-948246.html
Levitee Labs ($LVT $LVT.c) is a functional mushrooms and integrated wellness company that’s dedicated to transforming mental health, addiction and pain management care.
Their portfolio of assets includes:
- ACT Medical Centers: addiction and pain treatment clinics
- Block MD: a company with approval for prescriptions in addiction treatment
- Earth Circle Organics: Wholesaler of supplements and superfood products
Be the first to comment on this post